Omacetaxine News and Research

RSS
ChemGenex Pharmaceuticals to present updated clinical data from its clinical trials with Omapro

ChemGenex Pharmaceuticals to present updated clinical data from its clinical trials with Omapro

EMEA determines MAA for omacetaxine mepesuccinate for treatment of CML patients

EMEA determines MAA for omacetaxine mepesuccinate for treatment of CML patients

FDA accepts ChemGenex Pharmaceuticals' NDA for Omapro

FDA accepts ChemGenex Pharmaceuticals' NDA for Omapro

Chemgenex completes NDA submission for its omacetaxine mepesuccinate to the FDA

Chemgenex completes NDA submission for its omacetaxine mepesuccinate to the FDA

ChemGenex’s Omacetaxine to be showcased in three oral oresentations at EHA

ChemGenex’s Omacetaxine to be showcased in three oral oresentations at EHA

Data suggesting that omacetaxine can eradicate leukemic stem cells may offer a breakthrough for CML

Data suggesting that omacetaxine can eradicate leukemic stem cells may offer a breakthrough for CML